DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more



Diagnostic Rentability of Screening for Associated Conditions in Calcium Pyrophosphate Deposition Disease Patients

Information source: Sociedade Galega de Reumatoloxía
Information obtained from ClinicalTrials.gov on December 31, 2007
Link to the current ClinicalTrials.gov record.

Condition(s) targeted: Chondrocalcinosis

Phase: N/A

Status: Completed

Sponsored by: Sociedade Galega de Reumatoloxía

Official(s) and/or principal investigator(s):
José M Pego-Reigosa, MD, PhD, Principal Investigator, Affiliation: Meixoeiro Hospital, Vigo (Pontevedra) SPAIN

Summary

The purpose of this study is to determine whether thorough analytical evaluation is useful to diagnose metabolic conditions associated to calcium pyrophosphate deposition disease.

Clinical Details

Official title: Appraisal of the Diagnostic Rentability of Thorough Analytical Screening Searching Associated Conditions in Patients Newly Diagnosed With Calcium Pyrophosphate Dihydrate Deposition Disease

Study design: Natural History, Longitudinal, Case Control, Prospective Study

Detailed description: The diagnostic usefulness of screening for hyperparathyroidism, hemochromatosis, hypothyroidism and hypophosphatasia in patients diagnosed with calcium pyrophosphate dihydrate (CPPD) deposition disease is uncertain. Patients diagnosed with CPPD deposition disease were compared to patients with rheumatoid arthritis and psoriatic arthritis over a 9-year period. All patients were prospectively followed for at least 12 months. Serum calcium, phosphorus, alkaline phosphatase, thyroid-stimulating hormone, ferritin, iron, and total iron binding capacity were determined in all patients.

Eligibility

Minimum age: N/A. Maximum age: N/A. Gender(s): Both.

Criteria:

Inclusion Criteria: Patients diagnosed as having calcium pyrophosphate dihydrate deposition disease. Exclusion Criteria: Patients mimicking a rheumatoid arthritis disease, with positive rheumatoid factor or with psoriasis.

Locations and Contacts

Meixoeiro Hospital, Vigo, Pontevedra 36214, Spain
Additional Information

Starting date: January 1997
Ending date: December 2006
Last updated: March 27, 2007

Page last updated: December 31, 2007

-- advertisement -- The American Red Cross
We comply with
HONcode standard.
Verify here.
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2009